• Lahontan Gold Corp finalizes exploration plan for Santa Fe Operations, a significant milestone that qualifies the company for the National Environmental Policy Act (“NEPA”) assessment, a crucial step in ensuring environmentally responsible mining practices.
• LGC’s first phase 2025 drilling sets the tone for operational expansion with gold intercepts at York and a stacked zone of oxide gold mineralization at Slab Zone.
• These updates highlight the company’s broader mission: To explore and exploit its mineral reserve in Nevada, maximizing the production potential of the Santa Fe Mine while optimizing shareholder investments. This mission is underpinned by our commitment to sustainable and responsible mining practices, ensuring the long-term viability of our operations and the communities we operate in.
• Progress in permitting processes positions Lahontan for speedy production and portfolio growth in the coming year.

Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) is scaling up efforts at the Santa Fe Mine Project through impressive Phase One drill results and regulatory approvals. Known for its flagship Santa Fe Mine project and four silver and gold assets in the Walker Lane trend in Nevada, the company is expanding and exploring resources as it plans to begin production in earnest (ibn.fm/WD0T4).

The company received operational green light from the Bureau of Land Management, permitting it to commence environmental assessment. Latest drill results show that the Santa Fe mine field still has significant gold deposits to mine. These latest developments underscore Lahontan’s dual strategy of accelerating its permitting process and increasing its resource base, making it possible for more exploration in the short term and full-scale mine development in the foreseeable future (ibn.fm/irqyB).

The global gold mining industry is at the forefront of the mining sector and is expected to reach 3,200 metric tonnes in production by 2025 as international investments in the sector increase. With an estimated size of over $1.5 trillion, the global mining market’s enduring value is built on gold’s legacy as an inflation hedge, store of wealth, and its use in electronics, jewelry, and technology. China, the USA, Russia, Australia, and Canada currently produce over 50% of the world’s total output. Most of the top mining companies globally are integrating satellite data and artificial intelligence into their operations to optimize production (ibn.fm/hfEgp).

With its base in one of the best mining areas globally, Lahontan has been expanding its resource base using a well-crafted strategy for development in the short term. As part of its plans for 2025, the firm intends to begin phase two drilling at Slab and York, drill test the West Santa Fe project, and work on the Santa Fe mine plan. These strategic initiatives are designed to increase our resource base, optimize our production processes, and position us for sustained growth and profitability in the years to come.

The progress made so far highlights Lahontan’s plan to make the Santa Fe Mine a leading producer of silver and gold in Walker Lane. Initial economic assessment carried out in 2024 shows a pre-tax Net Present Value of $265 Million and an impressive 41% Internal Rate of Return based on current gold valuation. The company has raised over $12.5 million since its 2022 initial public offering and boasts a solid management team that has successfully handled numerous high-value projects. With phase two drill plans already in the works for later in the year and a strong push for the expansion of Santa Fe’s gold resource, the company is well placed to give short-, medium-, and long-term return on investment for its shareholders.

For more information, visit the company’s website at www.LahontanGoldCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to LGCXF are available in the company’s newsroom at ibn.fm/LGCXF

• West Vault owns 100% of the fully permitted Hasbrouck Gold Project in Nevada, offering immediate construction readiness in a world-class jurisdiction.
• The project demonstrates compelling “base case” economics, including a 51% after-tax IRR and US$206 million NPV at $1,790 gold, based on a 2023 Pre-feasibility Study.
• Proven and Probable Mineral Reserve of 753,000 oz in 44.02 million tons at a grade of 0.017 oz Au/ton.
• Large land package with multiple exploration targets.
• With an efficient corporate structure and a burn rate of approximately US$1 million per year, the company can maintain low-cost optionality.
• Management and insiders hold significant equity, aligning closely with shareholder interests and long-term value creation.
• The company is strategically positioned to benefit from a potential gold bull cycle, with zero near-term construction risk and full exposure to price upside.

West Vault Mining (TSX.V: WVM) (OTCQX: WVMDF) is a development-stage gold company focused on maximizing shareholder value through a low-risk, cash-conservative strategy. The company has followed a disciplined model of acquiring, advancing, and holding high-quality gold projects in premier jurisdictions, with the goal of monetizing these assets as market conditions become favorable. Its core emphasis is on controlling dilution and timing development decisions to optimize shareholder returns across the commodity cycle.

Since its formation following the successful C$424 million sale of West Timmins Mining in 2009, West Vault has remained laser-focused on opportunities in North America’s most prolific gold-bearing regions. This strategy has led to the acquisition and advancement of its flagship Hasbrouck Gold Project in Nevada, which is permitted and construction ready.

With a highly experienced management team and board that emphasize transparency, capital discipline, and long-term alignment with shareholders, West Vault is positioned as a unique vehicle offering exposure to gold price upside without the risks associated with early-stage construction.

The company is headquartered in Vancouver, British Columbia.

Project

West Vault controls a 100% interest in the Hasbrouck Gold Project, located between Tonopah and Goldfield in Nevada’s prolific Walker Lane Trend. The project comprises two primary oxide gold deposits—Three Hills and Hasbrouck—spanning a 10,500-acre land package. Both deposits are situated above the water table, with excellent infrastructure access including nearby grid power, highway connections, and water rights.

The company’s strategy is grounded in maintaining shovel-ready optionality. The most recent Pre-feasibility Study “base case”, completed in January 2023 by RESPEC Company LLC, reaffirmed the strength of the Hasbrouck Project, demonstrating an after-tax Net Present Value (NPV5%) of US$206 million and an Internal Rate of Return (“IRR”) of 51% at a gold price of $1,790/oz—well below current prices. In the Pre-feasibility Study sensitivity table, a $2,600/oz gold price resulted in an after-tax Net Present Value (NPV5%) of US$503 million and an Internal Rate of Return (“IRR”) of 110%.  Phase 1 (Three Hills Mine) is expected to require a modest initial capital investment of US$66 million in 2023 dollars, with the Phase 2 (Hasbrouck Mine) development planned to be funded through free cash flow from Three Hills. Average gold production is projected at 71,000 ounces per year with an all-in sustaining cost (“AISC”) of US$877 per ounce.

The project benefits from a low strip ratio (1.1:1), no pre-stripping requirements at the first pit, and a simple run-of-mine heap leach process with a 75% average gold recovery based on 13 metallurgical test programs. In addition to its existing Mineral Reserves and Resources, West Vault retains strong exploration upside, including intercepts outside the current resource model and a 1% NSR royalty on properties adjacent to Hasbrouck, enhancing long-term value potential.

Market Opportunity

West Vault’s cash-conservative approach and construction-ready asset position the company to capitalize on favorable shifts in the gold market without taking on near-term development or financing risk.

According to J.P. Morgan Research, gold prices are forecast to average $3,675 per ounce by the fourth quarter of 2025 and trend toward $4,000 per ounce by mid-2026, driven by persistent geopolitical tensions, demand rebasing, and recessionary tailwinds. With its permitted status, minimal overhead, and leverage to gold price appreciation, West Vault is strategically positioned to benefit from these macroeconomic tailwinds.

Leadership Team

Peter Palmedo, Chairman and Director, is the founder and president of Sun Valley Gold LLC, where he has spent more than 25 years investing in precious metals as a strategic asset class. Prior to founding SVG, he was a principal at Morgan Stanley & Co., specializing in equity portfolio risk management and derivatives. He served as a director of Chesapeake Gold Corp. until 2013 and joined the board of West Vault in 2019.

Sandy McVey, Chief Executive Officer and Chief Operating Officer, is a Professional Mining Engineer and registered Project Management Professional with over 30 years of experience in underground and surface mine operations, heavy civil construction, and mine development. He joined West Vault Mining in 2012 to lead the advancement, permitting, and construction of the company’s projects and has been instrumental in acquiring and bringing the Hasbrouck Gold Project to a construction-ready state.

Frank Hallam, Chief Financial Officer and Corporate Secretary, is a Chartered Professional Accountant with more than 30 years of experience in the mining, minerals, and petroleum industries. He has served as an operator, principal, and founder of several TSX and NYSE American companies, including Platinum Group Metals, MAG Silver, and West Timmins Mining. He has raised over $2 billion in public offerings and been directly involved in numerous M&A transactions, including the C$424 million sale of West Timmins and the billion-dollar acquisition of Lake Shore Gold by Tahoe Resources.

For more information, visit the company’s website at www.WestVaultMining.com.

NOTE TO INVESTORS: The latest news and updates relating to WVMDF are available in the company’s newsroom at https://ibn.fm/WVMDF

• Bolivia heads into an October presidential runoff, signaling a possible shift toward more pro-business policies, with the end of MAS’s political dominance hopefully reducing barriers to foreign investment, including in the mining sector.
• Bolivia has the world’s largest lithium reserves and is the fourth-largest silver producer, yet much of the country’s mineral-rich territory remains unexplored due to languid government support.
• New Pacific Metals owns two of the world’s largest undeveloped silver projects: Silver Sand and Carangas.
• Rising global silver demand, particularly from the solar industry, adds urgency to new project development.

Running a mining company in Bolivia has long meant navigating uncertainty. Heavy state involvement, slow permitting, and regulatory hurdles have discouraged outside capital, leaving vast parts of the country’s mineral wealth untapped. But following Bolivia’s August 17 election, the political environment could be shifting. The ruling Movimiento al Socialismo (MAS) party, dominant for two decades, lost its grip on national leadership (https://ibn.fm/v0s8U). The presidential race now advances to an October 19 runoff between a centrist and a right-wing candidate. While their policy details differ, both contenders have signaled possible openness to foreign investment and stronger trade ties.

For New Pacific Metals (NYSE American: NEWP) (TSX: NUAG), a Canadian exploration and development company, the runoff represents more than just a political transition. It may open the door to advancing projects that could position Bolivia as a leading supplier of silver to the global market.

Bolivia is already the world’s sixth-largest silver producer, contributing 5% of global output in 2023, according to GlobalData (https://ibn.fm/XwAVu). Yet more than 60% of its national territory remains unmapped or unexplored. Geological indicators suggest large untapped deposits across the Andes and highlands (https://ibn.fm/z4gAp).

New Pacific’s flagship Silver Sand and Carangas projects are discoveries made within the last five years and represent two of the world’s largest undeveloped silver deposits. They stand out for their scale and grade. Together, Silver Sand and Carangas could position New Pacific among the top global primary silver producers, with potential combined output of nearly 19 million ounces annually when production begins.

Bolivia’s mining legacy includes Cerro Rico in Potosí, one of history’s richest silver deposits, which helped finance Spain’s empire. That past underlines the potential of today’s underexplored regions. The challenge has been bringing in new capital. While Bolivia updated its mining law in 2014 with private-sector input, the approval process remains slow. Without faster permitting, even high-quality projects risk delay.

With limited new silver discoveries globally, high-grade deposits are increasingly scarce. This scarcity coincides with sharply rising demand. Industrial silver demand hit a record 20,353 tonnes in 2023, up 11% from the prior year, driven by solar panel manufacturing (https://ibn.fm/9Bagv). Projections suggest the solar industry alone will require 273 million ounces annually by 2030. By 2050, renewable infrastructure could consume more silver than has been mined in the past 500 years combined.

Such figures highlight the value of developing Bolivia’s silver belt, where New Pacific is one of the few international players positioned with advanced projects.

The October runoff does not eliminate Bolivia’s political and regulatory risks. But a departure from MAS’s state-heavy model could ease investor concerns. Both candidates have pledged to encourage outside participation, particularly in lithium and silver. For New Pacific, already established in the country, that creates a major potential turning point. If the next administration lowers barriers and accelerates permitting, the company’s assets could move closer to production or become targets for acquisition by larger miners.

For more information, visit the company’s website at www.NewPacificMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to NEWP are available in the company’s newsroom at https://ibn.fm/NEWP

• Four-property portfolio in Nevada’s Walker Lane anchored by the Santa Fe Mine project with over 2 million ounces of gold equivalent resources
• Past production at Santa Fe included 359,202 ounces of gold and 702,067 ounces of silver from open pit, heap-leach operations between 1988 and 1995
• Development strategy leverages existing infrastructure and favorable jurisdiction to advance toward target production in 2027

A New Era for U.S. Gold Development

Gold’s role as a financial haven has grown as global markets navigate persistent inflation, geopolitical instability, and central bank accumulation. Prices remain elevated, but the supply side tells a different story: U.S. production has been in long-term decline, creating urgency for new domestic projects in mining-friendly jurisdictions. For investors, this environment places exploration and development companies in the spotlight, particularly those with sizable resources in stable regions.

Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) embodies this trend through its strategic portfolio in Nevada’s Walker Lane, a district long recognized for prolific gold production and supportive infrastructure. With its flagship Santa Fe Mine project and three additional properties, Lahontan is positioning itself to be part of the next wave of U.S. gold producers.

Santa Fe Mine: A Resource Foundation with History

The centerpiece of Lahontan’s portfolio is the 26.4 km² Santa Fe Mine, which already boasts a NI 43-101 compliant resource base of more than 2 million gold equivalent ounces. Historical production between 1988 and 1995 yielded over 1 million ounces in gold and silver, confirming the project’s mineralization and viability under open-pit, heap-leach operations.

The mine’s past success, coupled with modern exploration and resource modeling, underscores its potential to be redeveloped into a significant gold-silver producer. Current work programs continue to refine pit designs, with Lahontan’s recent property consolidation efforts further unlocking opportunities for optimized mine planning and future expansion.

Nevada Portfolio Provides Depth and Optionality

While Santa Fe serves as the anchor, Lahontan’s three other projects, West Santa Fe, Moho, and Redlich, add depth and optionality to the company’s pipeline.

• West Santa Fe, located just 13 kilometers from the flagship, has delivered encouraging surface results suggesting satellite potential that could extend mine life and throughput
• Moho offers high-grade underground targets, providing exposure to mineralization styles complementary to the open-pit profile of Santa Fe
• Redlich emphasizes silver-rich mineralization, giving Lahontan exposure to an additional precious metal that often strengthens project economics

Together, these projects position Lahontan as more than a single-asset developer, enhancing resilience and long-term value creation potential.

Strategic Advantages of Nevada Operations

Nevada remains North America’s premier gold jurisdiction, offering reliable permitting processes, supportive infrastructure, and proximity to processing facilities. The Walker Lane corridor, home to more than 40 million ounces of historical production, continues to attract significant industry interest, highlighted by recent acquisitions and consolidation moves by larger players.

For Lahontan, the jurisdictional advantage translates into reduced development risk and lower capital intensity. Access to established roads, power, and water infrastructure shortens timelines and supports cost-effective project advancement.

Positioned for Next Cycle of U.S. Production

With its 2-million-ounce resource base, proven production history, and pipeline of additional projects, Lahontan Gold is well positioned as the gold sector enters a new cycle of investment and development. The company’s timeline targets early 2027 for initial production at Santa Fe, aligning with sustained demand for domestic supply and favorable price dynamics.

In a market increasingly rewarding companies with advanced, jurisdictionally advantaged projects, Lahontan stands out as a Nevada-focused junior aiming to bridge the gap between exploration potential and future gold production.

For more information, visit the company’s website at www.LahontanGoldCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to LGCXF are available in the company’s newsroom at ibn.fm/LGCXF

• As budgets tighten and demands intensify, CMOs are questioning traditional marketing models
• ONAR is seizing this moment to transform the agency paradigm through its leverage of proprietary AI & technologies
• In addition, the company is pioneering innovation labs where marketing ideas evolve in real time

Agencies often fall short in balancing tight budgets with delivering true performance, but ONAR Holding Corp. (OTCQB: ONAR) is shaking things up. Through innovative models that blend services with SaaS, offer fixed-fee arrangements and build live innovation hubs, ONAR is redefining how agencies can empower chief marketing officers (“CMOs”) and drive measurable results.

Budgets and results often fail to align in traditional agency setups. Marketing budgets, once averaging around 11% of company revenue, dipped to just 7.7% in 2024, according to Gartner, making resource allocation more difficult than ever (ibn.fm/yBy6W). CMOs increasingly feel constrained; 73% are expected to do “more with less,” and 64% say their budgets do not match their aspirations for growth and brand impact. 

Meanwhile, generative AI is beginning to chip away at reliance on external partners: 22% of CMOs report artificial intelligence (“AI”) has reduced their dependence on agencies, and 39% plan to trim agency spend through roster streamlining or renegotiation (ibn.fm/iV9ex). These shifts reflect a growing misalignment between traditional agency models and the expectations of modern marketing leaders.

As budgets tighten and demands intensify, CMOs are questioning traditional models. Bain & company highlights that managing multiple external agencies leads to inefficiencies, escalating costs and stifles innovation (ibn.fm/SyvXk). Rather than continue with fragmented, slow-moving partnerships, brands are increasingly centralizing capabilities or renegotiating and reallocating tasks in-house. This trend underscores a need for more agile, accountable and transparent partnership models in marketing.

ONAR is seizing this moment to transform the agency paradigm through its unique, technology-first network of marketing companies. By integrating proprietary AI and technology platforms, ONAR provides a flexible, scalable and accountable infrastructure tailored for mid-market and growth-stage businesses. ONAR’s model combines full-service capabilities with fixed-fee pricing structures, allowing CMOs to forecast more accurately and align outcomes with investment, addressing a top frustration with traditional agencies.

In addition, ONAR is pioneering innovation labs where marketing ideas evolve in real time. Instead of pitch presentations alone, campaigns are pressure-tested with data, technology and forecasts baked in upfront, creating validated strategies before full-scale rollout. This real-world testing ensures that concepts survive audience scrutiny and analytics feedback, building both confidence and higher campaign ROI. On the tech side, ONAR’s AI-powered software streamlines workflow, optimizes campaign reach across channels, predicts outcomes and tightens feedback loops so execution becomes more strategic, not reactionary.

This holistic approach aligns well with how marketing leaders plan to adapt. With more than 19% of marketing budgets allocated to MarTech today, and expected to reach over 23.5% within a year and nearly 31% in five years (ibn.fm/Xquwv), the demand for integrated technology platforms is booming. ONAR’s emphasis on enhanced services taps directly into this growth, providing both human creativity and digital efficiency in one package.

Clearly, ONAR Holding is responding to the modern CMO’s call for agency accountability, flexibility and performance alignment. By pairing acquisitions of effective agencies with proprietary AI tools, fixed-fee structures and live innovation hubs, ONAR offers a new way forward for marketing leaders. In an era of tight budgets, shrinking agency reliance and intense performance expectations, ONAR’s model is not just innovative, it’s essential.

For more information, visit the company’s website at www.ONAR.com.

NOTE TO INVESTORS: The latest news and updates relating to ONAR are available in the company’s newsroom at https://ibn.fm/ONAR

• PowerBank has secured site control for a 2.8 MW solar project in upstate New York and a 3.16 MW project in Pennsylvania.
• The Day Hollow, NY project could supply enough electricity for 374 homes and qualify under New York’s Value of Distributed Energy Resources (“VDER”) program.
• Both projects are progressing to the interconnection study phase, a key step before construction.
• The Pennsylvania project depends on final approval of House Bill 1842, which would allow community solar programs in the state.
• PowerBank has now developed more than 100 MW of renewable energy projects and has a pipeline exceeding 1 GW, with a strategy that creates value for all stakeholders by growing its portfolio of cash generating IPP assets for recurring revenue or completing strategic project sales.

Disseminated on behalf of PowerBank Corporation

PowerBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., has announced two new U.S. developments in New York and in Pennsylvania, as it continues expanding its North American footprint.

The 2.8 MW Day Hollow solar project in upstate New York has secured site control, allowing it to move forward into the interconnection study phase, according to a company news release (https://ibn.fm/f8teZ). The project is expected to qualify under New York’s Value of Distributed Energy Resources (“VDER”) compensation mechanism, which sets fair payments for renewable power fed into the grid. At an estimated average rate of $0.0971/kWh in its first year, the framework adds financial certainty to the project’s future cash flow.

Once permitted and financed, Day Hollow will be built as a community solar project, delivering electricity to the grid and offering subscriber – renters, businesses, and homeowners – bill credits and savings without requiring rooftop solar installations. PowerBank estimates the site could generate enough clean energy to supply 374 households.

The project supports New York’s Climate Leadership and Community Protection Act, which sets a target of 6 GW of solar capacity by 2025. The state is already the largest U.S. market for community solar, accounting for nearly one-third of the 6.2 GW installed nationwide. By integrating into this framework, PowerBank positions itself to capture both environmental and economic benefits while contributing to state policy goals.

Shortly before the New York announcement, PowerBank revealed that its 3.16 MW Honesdale project in Pennsylvania had also secured site control and is advancing to the interconnection phase (https://ibn.fm/8guk3). Like Day Hollow, Honesdale is planned as a community solar initiative, but its development depends on enabling legislation.

Pennsylvania’s House of Representatives passed House Bill 1842 in 2024 and again in May 2025, this time with amendments, to authorize community solar programs. The bill is currently under review in the Senate. If passed, it would open the state to companies like PowerBank, which could bring clean energy options to a broad range of households, including lower-income residents.

PowerBank brings significant execution experience to these projects. The company has already completed more than 100 MW of renewable projects across North America and is developing a pipeline exceeding 1 GW. Its business model spans utility-scale, commercial, municipal, and residential off-takers, diversifying its revenue base.

The company also integrates Battery Energy Storage Systems (“BESS”) into its development strategy, offering flexibility and grid stability alongside solar generation. This mix of community-based projects and energy storage positions PowerBank to meet evolving needs in the North American energy transition.

PowerBank emphasizes that its projects can make renewable energy accessible to renters and households that would not otherwise benefit from rooftop installations. In turn, this expands the market reach for solar, particularly in states with ambitious climate and energy goals.

For more information, visit the company’s website at https://PowerBankCorp.com.

This report contains forward looking information. Please refer to the press releases entitled “PowerBank Advances 2.8 MW Day Hollow Solar Project in New York, With Capacity to Power 374 Homes” and dated September 2, 2025, and “PowerBank Advances 3.16 MW Honesdale Project in Pennsylvania” and dated August 28, 2025, for additional details on the information, risks and assumptions.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

• Proprietary machine-learning reconstruction algorithm trained on 15 years of breast CT data positions IzoView to redefine global imaging standards
• Self-supervised approach works on X-ray data before reconstruction, avoiding the delays that cripple competing AI methods
• Trade secret protection and modality-specific training create durable competitive moats in a crowded, commoditized AI field

The medical imaging industry stands at a pivotal juncture. Artificial intelligence promises to revolutionize diagnostics, yet most AI applications in CT imaging remain stuck in theory rather than practice. Conventional AI denoising tools either demand prohibitive computing power, compromise diagnostic clarity, or require impractical training datasets that increase patient exposure. The gap between AI’s promise and clinical reality has created a rare opportunity for innovators who can bridge it.

At the heart of sustainable differentiation lies data and intellectual property. As general-purpose AI models become commoditized, long-term advantage comes from domain-specific training, proprietary datasets, and protected algorithms designed for real-world clinical workflows. This is where Izotropic (CSE: IZO) (OTCQB: IZOZF) is carving out a moat with its IzoView Breast CT system.

In partnership with Johns Hopkins University School of Medicine, Izotropic has developed a proprietary machine-learning reconstruction algorithm for its IzoView Breast CT Imaging System. The technology addresses the long-standing trade-off between image quality and radiation dose.

Lower doses protect patients but produce noisy, grainy images that limit diagnostic confidence. Traditional fixes fall short: Model-Based Iterative Reconstruction (“MBIR”) requires minutes per image, untenable when breast CT generates up to 500 images per scan, while Deep Machine Learning Reconstruction (“DMLR”) needs paired high/low-dose scans, increasing radiation exposure and confusing algorithms with correlated noise.

Workflow-Compatible Approach

IzoView’s algorithm flips the script. Instead of cleaning images after reconstruction, it works directly on raw X-ray detector data before reconstruction begins. This shift enables superior denoising without altering natural breast tissue texture.

The self-supervised method eliminates the bottlenecks of MBIR and the unsafe training demands of DMLR. For the first time, clinicians can get optimized images at lower doses without sacrificing workflow efficiency, an innovation with immediate clinical relevance.

By solving the practical barriers that have kept AI out of breast CT, Izotropic positions IzoView to set new global standards for image quality, patient safety, and regulatory benchmarks in breast imaging.

The algorithm’s real edge lies in its foundation: 15 years of breast CT–specific imaging data. This dataset is deep, highly specialized, and nearly impossible for competitors to replicate without similar decades-long investment and clinical collaboration.

Breast CT is a technically unique modality, distinct from general CT. Models trained on generic datasets consistently fail in this domain. Izotropic’s accumulated data not only gives it a defensible lead but also creates a flywheel effect: better algorithms generate better data, which in turn improves algorithms, widening the moat year after year.

Protected by Trade Secrets, Not Patents

Izotropic has opted for trade secret protection rather than patents, keeping the algorithm’s architecture and training methods undisclosed indefinitely. This strategy avoids the disclosure requirements of patents while making reverse engineering exceedingly difficult.

Combined with the proprietary dataset, trade secret protection creates a multi-layered defense. At a time when large language models and generalized AI systems risk commoditization, modality-specific, data-rich, and legally shielded solutions like IzoView’s represent the true scarce assets in healthcare AI.

Positioned for AI-Driven Healthcare Evolution

The integration of IzoView’s algorithm aligns with two unstoppable healthcare trends: AI adoption and precision diagnostics. Radiologists increasingly rely on computer-aided tools, but these tools are only as good as the data they process. By delivering high-quality, low-dose images, IzoView creates the optimal input for next-generation AI diagnostic platforms.

The approach also strengthens regulatory positioning, since low radiation exposure and high diagnostic accuracy are both critical review criteria. Clinically, it delivers measurable value: improved diagnostic confidence, safer protocols, and no disruption to screening workflows.

Market Implications

IzoView’s AI-enhanced platform differentiates it from legacy CT systems and new AI entrants alike. Instead of theoretical performance gains that falter in real-world settings, Izotropic has focused on practical, deployable solutions. That focus translates into value propositions across the clinical, operational, and economic spectrum.

Healthcare providers gain confidence in diagnoses, patients receive lower radiation doses, and institutions maintain efficiency. Meanwhile, the company locks in competitive positioning by leveraging specialized data and protected algorithms.

Investment Outlook

Izotropic’s integration of a proprietary AI reconstruction algorithm into IzoView represents more than a technical upgrade; it marks a strategic inflection point. Fifteen years of data, a novel approach that fits clinical workflows, and a robust intellectual property strategy together create a moat that general-purpose AI cannot cross.

As imaging converges with artificial intelligence, IzoView is positioned not just to participate but to lead. In a market where most AI promises fade in translation to practice, Izotropic offers a rare case where innovation, data, and protection align to create an unassailable competitive advantage.

For more information, visit the company’s website at www.IzoCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to IZOZF are available in the company’s newsroom at ibn.fm/IZOZF

• Advanced processing technology allows the company to re-process mine waste into scalable gold and silver production.
• Latest PEA update for Quebec’s Montauban project indicates clear path to production.
• The company has entered a binding memorandum to form a joint venture in Colombia for the development and reprocessing of gold and silver-bearing tailings.

ESGold (CSE: ESAU) (OTCQB: ESAUF) recently released its updated PEA (Preliminary Economic Assessment) for the company’s Montauban Gold-Silver Project in Quebec, verifying the projects positive economics and path to production (https://ibn.fm/o6nCU). The updated PEA confirms Montauban’s transformation into a production asset, including: 

• low capex,
• high-margin tailings reprocessing, and the
• infrastructure in place to achieve first production in the near-term

Importantly, ESGold benefits from more than C$20 million in tax-loss carry forwards, which are expected to substantially offset taxable income during the first three years of production, enhancing early-stage free cash flow.

The company is introducing advanced processing technology that re-processes mine waste into scalable gold and silver production, as also revealed in its proposed fully permitted joint venture in Colombia (https://ibn.fm/JqoIH). ESGold is building on its Québec pilot with a scalable, innovative model designed to replicate and grow across the Americas.

In Colombia, the company announced that it has now entered a binding memorandum of understanding with Colombia’s Planta Magdalena S.A.S. (“Planta”) to form the JV with the aim of developing and reprocessing fully permitted, gold- and silver-bearing tailings in that country’s Department of Bolívar.

The Bolívar JV marks ESGold’s first expansion of its scalable tailings to cash flow model beyond Québec, a key test project for commencing similar operations across multiple jurisdictions. The announcement showcases ESGold’s potential for scalable production is at par with leading mining companies that are leveraging strategic planning and advanced technology to strengthen their international position.

By mining responsibly, the company is not only unlocking reserves of mineral wealth but also turning mining waste into sustainable growth, a win-win for ESGold.

For more information, visit the company’s website at https://esgold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

• Company releases report updating status of proprietary 12-lead ECG synthesis software for arrhythmia assessment.
• Earlier this year, HeartBeam submitted its software application to the U.S. Food and Drug Administration.
• Plans will ensure that healthcare providers and patients can seamlessly integrate the HeartBeam system into clinical workflows and home-monitoring routines.

In its most recent quarterly update, HeartBeam (NASDAQ: BEAT) is reporting that the company is on the verge of revolutionizing cardiac diagnostics with its groundbreaking ECG technology. The company is actively preparing for FDA 510(k) clearance of its innovative 12-lead ECG synthesis software for arrhythmia assessment while executing comprehensive commercial readiness plans for a technology that could transform how heart health is monitored both in clinical and home settings (https://ibn.fm/dz7rY).

“In the quarter, we continued to engage in positive and productive discussions with the FDA on the 12-lead ECG synthesis software submission for arrhythmia assessment, and we continue to anticipate clearance by the end of the year. . . . That clearance, together with our foundational clearance, will form the basis for our commercial launch,” said HeartBeam CEO Robert Eno. “We continue to make significant progress with commercial readiness plans, which is positioning us for a successful launch following 510(k) clearance of our 12-lead synthesis software.”

Earlier this year, HeartBeam submitted its 12-lead ECG synthesis software application to the U.S. Food and Drug Administration (“FDA”). The FDA submission was supported by robust clinical evidence and data demonstrating both safety and effectiveness. The company is engaged in ongoing discussions with the FDA regarding its 510(k) application and anticipates clearance by the end of 2025. FDA clearance would mark a major milestone, allowing HeartBeam to expand access to this cutting-edge technology beyond clinical environments.

To prepare for commercial launch, HeartBeam has developed comprehensive readiness plans. These plans include finalizing a cardiology reader service that allows on-demand physician review of synthesized 12-lead ECGs, establishing customer service infrastructure and implementing contract manufacturing and logistics systems. The goal is to ensure that healthcare providers and patients can seamlessly integrate the HeartBeam system into clinical workflows and home-monitoring routines.

HeartBeam’s innovative approach has been recognized within the medical industry. The company has received more than 20 patents for its cardiac diagnostic technology, highlighting the uniqueness of its methods and the potential impact on heart care. In addition, HeartBeam was awarded the Innovation Award in Remote Cardiac Diagnostics as part of the 2025 Medical Device Network Excellence Awards for its groundbreaking ECG technology, and was named a finalist in the 2025 Octane High Tech Awards, which recognizes innovators, entrepreneurs and technology leaders with a presence in Orange County. These industry awards further validate the clinical relevance and technological ingenuity of HeartBeam’s solutions.

Looking forward, HeartBeam plans to initiate commercialization immediately upon receiving FDA clearance. The company’s vision is to empower patients and healthcare providers by offering a portable, cable-free ECG solution that combines clinical-grade accuracy with ease of use. This innovation is poised to reduce the burden on healthcare facilities, improve patient engagement, and increase the availability of high-quality cardiac monitoring, particularly in underserved areas or for patients requiring frequent arrhythmia assessments.

The traditional 12-lead ECG is essential for timely and accurate treatment decisions and is the cornerstone of cardiac care. Despite its clinical value, traditional 12-lead ECG systems are cumbersome, requiring multiple electrodes and wires, and are typically restricted to hospital or clinic use. This limits accessibility for patients and may result in delays in care.

HeartBeam’s synthesis software addresses these limitations by generating a full synthesized 12-lead ECG from a single, compact device for arrhythmia assessment. The system captures signals from three distinct directions and uses advanced algorithms to reconstruct a complete synthesized 12-lead waveform (https://ibn.fm/ldKfq). This approach reduces patient setup time, eliminates the inconvenience of external cables, and facilitates at-home or remote monitoring. The synthesized ECG maintains high fidelity, ensuring that physicians receive the same level of diagnostic detail as traditional systems. Clinical data from the pivotal VALID-ECG study demonstrated a 93.4% overall diagnostic agreement, confirming that HeartBeam’s software can accurately support assessment of arrhythmias.

As the healthcare industry increasingly embraces telemedicine and remote patient monitoring, HeartBeam’s 12-lead ECG synthesis software represents a significant leap forward. By providing a high-fidelity, multidirectional signals of the heart in a compact form factor, the system stands to transform cardiac care, making it more accessible, efficient and patient centered. HeartBeam continues to advance its mission of modernizing heart health monitoring, offering both physicians and patients the tools needed for proactive and informed cardiovascular care.

For more information, visit www.HeartBeam.com.

NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT

• Exclusive U.S. patent rights for computer-aided diagnosis (“CADx”) with breast CT secured through a global license with the University of California
• CADx planned as a post-market software upgrade, creating dual revenue streams via upgrade incentives and licensing
• Patent exclusivity paired with proprietary machine-learning reconstruction establishes a durable moat in dedicated breast imaging

The AI Integration Challenge in Medical Imaging

Artificial intelligence has long promised to revolutionize radiology, but most applications remain stuck between theoretical potential and real-world limitations. CADx systems can enhance detection, yet they face hurdles: lack of specialized datasets, workflow disruptions, and intellectual property barriers.

In breast imaging, the stakes are higher. Nearly half of screening patients present with dense breast tissue, where overlapping structures can mask cancers. General-purpose AI retrofits struggle to overcome these limitations. True innovation requires purpose-built platforms that integrate AI from the ground up.

Izotropic (CSE: IZO) (OTCQB: IZOZF) is addressing this head-on, securing exclusive rights to the only U.S. patent for CADx with breast CT, positioning its IzoView system as the first platform built for seamless AI integration in dedicated breast imaging.

Patent Acquisition Creates Strategic Differentiation

IzoView, Izotropic’s flagship 3D breast CT system, offers a powerful imaging alternative bridging the gap between DBT and MRI. The newly licensed CADx patent marks more than a technical addition; it creates clear separation from competitors.

CADx analyzes images to estimate malignancy likelihood, giving radiologists faster, more confident decision support. In breast imaging, CADx addresses the diagnostic gaps left by mammography, DBT, and MRI, whether it’s density masking cancers or overwhelming volumes of data.

The patent covers CADx specifically for breast CT. That technical specificity creates protection against competitors trying to bolt AI onto existing systems. Unlike generalized CADx adaptations, Izotropic’s exclusive license ensures only IzoView can legally integrate this capability into dedicated breast CT.

Phased Rollout Maximizes Market Potential

Izotropic is pursuing a phased commercialization strategy. IzoView will debut without CADx but with its proprietary machine-learning reconstruction algorithm, trained on 15 years of breast CT data, that enhances image quality at low radiation doses.

CADx will arrive as a post-market software upgrade, creating dual opportunities: early adopters gain integration incentives, while Izotropic establishes recurring revenue through software licensing. This approach allows the company to penetrate the market quickly, then layer on AI enhancements as regulatory approvals and workflow demand align.

Competitive Moat Through Integrated AI Architecture

The CADx patent complements Izotropic’s reconstruction algorithm, protected as a trade secret. Together, they form a multi-layered moat that competitors will find difficult to breach.

Most medical AI systems exist as standalone overlays, requiring extra hardware or workflow adjustments. IzoView avoids these pitfalls: both the platform and its AI were designed specifically for breast CT, ensuring seamless integration.

With CADx patent exclusivity blocking rival systems, and its reconstruction algorithm leveraging a dataset competitors cannot replicate, Izotropic has effectively locked down the high ground in breast CT AI.

Market Implications and Revenue Diversification

The patent’s commercial implications extend well beyond technical differentiation. In medical imaging, software upgrades increasingly drive growth, enabling providers to add functionality without costly equipment replacement.

For Izotropic, CADx unlocks recurring software licensing revenue that complements hardware sales. As IzoView’s installed base grows, this creates a compounding model of upfront system sales plus ongoing software monetization.

Exclusive CADx rights ensure IzoView is the only breast CT platform offering this level of AI integration, creating a sustainable competitive advantage as AI adoption accelerates across healthcare.

Investment Positioning

Izotropic’s CADx patent represents a pivotal milestone: it secures protected AI capabilities that extend the company’s existing technical leadership while creating software-driven revenue opportunities.

The commercialization strategy is pragmatic: launch first with IzoView’s core imaging strengths, then expand functionality with AI upgrades that enhance diagnostic accuracy and expand revenue per installation.

For investors, the combination of specialized hardware, protected AI software, and recurring revenue potential defines a compelling story. In an AI landscape where most competitors chase generalized solutions, Izotropic is carving out a defendable, first-mover position in one of the most challenging and valuable imaging domains: breast cancer detection.

For more information, visit the company’s website at www.IzoCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to IZOZF are available in the company’s newsroom at ibn.fm/IZOZF